[Fidanacogene elaparvovec (haemophilia B); assessment according to §35a Social Code Book (SGB) V; search for disease registries]

Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018005239
Original Title: Fidanacogen Elaparvovec (Hämophilie B)
Project Status: Completed
Year Published: 2023
English language abstract: There is no English language summary available
Publication Type: Full HTA
Country: Germany
MeSH Terms
  • Hemophilia B
  • Registries
  • Product Surveillance, Postmarketing
  • Genetic Therapy
  • Fidanacogene Elaparvovec
  • Hemophilia B
  • Registries
  • Product Surveillance – Postmarketing
  • Information Storage and Retrieval
Organisation Name: Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address: IQWiG, Im Mediapark, 8, DE-50670 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email: berichte@iqwig.de
Copyright: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.